Riskpilot← Back to searchSign inGet full accessLAMBERTSETER SPECSAVERS AS
ASActiveOrg 922205256Lambertsenter Senter Cecilie Thoresens Vei 17, 1153 OsloRetail sale of medical and orthopaedic goods · NACE 4774Est. 201911 employees
Revenue 2025
NOK 16M
+25% vs 2024
EBITDA margin
9.3%
+80% vs 2024
Equity ratio
16.0%
Financial strength
Net profit 2025
NOK 756K
+326% vs 2024
| Revenue | NOK 16M | +25% |
| EBITDA | NOK 1,5M | +80% |
| Net profit | NOK 756K | +326% |
| Total assets | NOK 4,3M | +20% |
| Equity | NOK 692K | +9% |
| Employees | 11 | — |
Legal name
LAMBERTSETER SPECSAVERS AS
Org number
922205256
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
11. februar 2019
Share capital
NOK 30 125
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Company purpose
Handel med optiske varer samt det som naturlig står i forbindelse med dette.
Address
Lambertsenter Senter Cecilie Thoresens Vei 17, 1153 Oslo
Phone
+4722747700
Email
lambertseter@no.specsavers.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 246 | 10 092 | 11 494 | 12 816 | 16 015 |
| Staff expenses | −995 | −2 988 | −3 408 | −3 762 | −4 549 |
| EBITDA | 241 | 717 | 759 | 827 | 1 484 |
| Depreciation & amort. | −51 | −462 | −529 | −487 | −440 |
| EBIT | 191 | 255 | 229 | 339 | 1 043 |
| Net financials | −9 | −49 | −50 | −55 | −20 |
| Profit before tax | 181 | 206 | 179 | 284 | 1 024 |
| Tax | 39 | 45 | 52 | 107 | 268 |
| Net profit | 142 | 161 | 127 | 177 | 756 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 405 | 4 591 | 4 405 | 3 613 | 4 332 |
| Equity | 172 | 333 | 459 | 636 | 692 |
| Long-term debt | 514 | 2 734 | 1 818 | 931 | 519 |
| Short-term debt | 1 718 | 1 525 | 2 128 | 2 046 | 3 121 |
| Total debt | 2 232 | 4 258 | 3 946 | 2 977 | 3 640 |
EBITDA margin
9.3%
This company
15.8%
Market median
-41% vs market
20212025
Equity ratio
16.0%
This company
38.2%
Market median
-58% vs market
20212025
Return on equity
109.2%
This company
18.4%
Market median
+493% vs market
20212025
Net profit margin
4.7%
This company
8.1%
Market median
-42% vs market
20212025
Asset turnover
3.70×
This company
1.12×
Market median
+230% vs market
20212025
Debt / equity
5.26×
This company
0.62×
Market median
-748% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-03-01 – 2024-02-29
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-03-01 – 2023-02-28
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-03-01 – 2022-02-28
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2021-02-28
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Board of Directors | 2020 | |
| Board of Directors | 2024 | |
| Former (4) | ||
| Board of Directors | 2020 – 2023 | |
| Board of Directors | 2020 – 2022 | |
| Chairman | 2020 – 2024 | |
| Board of Directors | 2020 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Norway Specsavers Ltd | Company | 50.21% | 50.21% | 2024 |
| Individual | 50.21% | 50.21% | 2022 | |
| Individual | 24.9% | 24.9% | 2024 | |
| Company | 24.9% | 24.9% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LAMBERTSETER SPECSAVERS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Richard Neil Owens | Chairman | 0 companies |
| Henning Jørgen Eriksen | Board of Directors | 0 companies |
| Jan Kristian Bjerke | Board of Directors | 0 companies |
| Henning Jørgen Eriksen Færden | Board of Directors | 0 companies |
| Nina Helen Kleppe | Board of Directors | 0 companies |
| Nigel David Parker | Chairman | 0 companies |
| Jan-Kristian Bjerke | Board of Directors | 0 companies |